AKEBIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

06 Nov 2026 09:58:42 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

05 Nov 2026 12:01:56 By NetDania Notify

Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

05 Nov 2026 07:10:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin

05 Nov 2026 07:00:01 By Nasdaq GlobeNewswire

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

29 Oct 2026 08:00:01 By Nasdaq GlobeNewswire

U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week

26 Oct 2026 09:20:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

22 Oct 2026 10:42:19 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

21 Oct 2026 09:45:25 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 Oct 2026 12:04:46 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

16 Oct 2026 09:47:07 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

15 Oct 2026 10:01:34 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

14 Oct 2026 09:46:02 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 Oct 2026 16:07:30 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

12 Oct 2026 09:45:25 By NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

09 Oct 2026 09:47:45 By NetDania Notify

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum

07 Oct 2026 08:00:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026

06 Oct 2026 08:00:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Oct 2026 16:05:00 By Nasdaq GlobeNewswire

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

14 Sep 2026 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

17 Aug 2026 10:18:26 By NetDania Notify